Trial Profile
A Drug-drug Interaction Study of Capecitabine and Celecoxib in Patients With Advanced Solid Malignancies
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Capecitabine
- Indications Solid tumours
- Focus Pharmacokinetics
- 30 Apr 2018 Status changed to discontinued due to slow accrual.
- 06 Oct 2017 Planned End Date changed from 1 Sep 2017 to 1 Jun 2018.
- 06 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Jun 2018.